Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis

Hemodialysis International

Volumn 11, Issue 3, 2007, Pages 315-321

  Del Valle, Elisa ^a   Negri, Armando L ^a,b   Aguirre, Cristina ^a   Fradinger, Erich ^a   Zanchetta, Jose R ^a  

^a UNIVERSIDAD DEL SALVADOR   (Argentina)

^b Instituto de Investigaciones Metabolicas   (Argentina)

Author keywords

Calcidiol; Chronic kidney disease; Hemodialysis; Vitamin D deficiency

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; PROTEIN; VITAMIN D;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CALCIUM BLOOD LEVEL; CATABOLISM; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEMODIALYSIS; HUMAN; INFLAMMATION; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC RATE; MINERAL METABOLISM; MULTIPLE REGRESSION; NUTRITION; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PREVALENCE; PROTEIN METABOLISM; SEASONAL VARIATION; SUN EXPOSURE; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WINTER;

ADULT; AGED; BODY MASS INDEX; CALCIFEDIOL; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEASONS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SUNLIGHT; VITAMIN D DEFICIENCY;

EID: 34250779828     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00186.x     Document Type: Article

References (34)

1. Qaw F, Calverley MJ, Schroeder NJ, Trafford DJ, Makin HL, Jones G. In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence of formation of 1 alpha, 25- and 1 beta, 25dihydrotachysterol metabolites and study of their biological activity. J Biol Chem. 1993; 268: 282-292.
2. Cunningham J, Makin H. How important is vitamin D deficiency in uremia? Nephrol Dial Transplant. 1997; 45: 46-51.
3. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. Am J Clin Nutr. 2004; 80: 1678S-1688S.
4. Schwartz GC, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev. 1998; 7: 391-395.
5. Segersten U, Correa P, Hewison M, et al. 25-hydroxyvitamin D (3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab. 2002; 87: 2967-2972.
6. Fournier A, Bordier P, Gueris J, et al. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: Grater effect of 25-hydroxycholecalciferol on bone mineralization. Kidney Int. 1979; 15: 196-204.
7. Birge SI, Hadddad JG. 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest. 1975; 56: 1100-1107.
8. Eastwood JB, Stamp TCB, de Wardener HE, Bordier PJ, Arnaud CD. The effect of 25-hydroxyvitamin D3 in osteomalacia of chronic renal failure. Clin Sci. 1977; 52: 499-508.
9. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42: 1-201.
10. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: A position paper. Med J Aust. 2005; 182: 281-285.
11. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Am Coll Nutr. 2003; 22: 142-146.
12. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: A population-based study of younger and older adults. Am J Med. 2004; 116: 634-639.
13. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial. BMJ. 2003; 326: 469.
14. Coen G, Mantella D, Manni M, et al. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int. 2005; 68: 1840-1848.
15. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hipovitaminosis D: Call for standardization. J Clin Endocrinol Metab. 2004; 89: 3152-3157.
16. Eastwood JR, Harris F, Stamp TCB, de Wardener HE. Vitamin-D deficiency in osteomalacia of renal failure. Lancet. 1976; 1209-1211.
17. Eastwood JB, Daly A, Carter GD, Alaghband-Zadeh J, de Wardener HE. Plasma 25-hydroxy-vitamin D in normal subjects and in patients with terminal renal failure on maintenance hemodialysis and after transplantation. Clin Sci. 1979; 57: 473-476.
18. Mason RS, Lissner D, Wilkinson M, Posen S. Vitamin D metabolites and their relationship to azotaemic osteodystrophy. Clin Endocrinol. 1980; 13: 375-385.
19. Koenig KG, Lindberg JS, Zerwekh JE, Padalino PK, Cushner HM, Copley JB. Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int. 1992; 41: 161-165.
20. Ishimura E, Nishizawa Y, Inaba M, et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999; 55: 1019-1027.
21. LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005; 45: 1026-1033.
22. González EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. Am J Nephrol. 2004; 24: 503-510.
23. Cooke NE, Haddad JG. Vitamin D binding protein. In: Feldman D, Glorieux FH, Pike JW eds. Vitamin D. San Diego: Academic Press; 1997: 87-104.
24. Rabkin R, Dahl DC. Hormones and the kidney. In: Schrier RB, Gottschalk CW eds. Diseases of the Kidney. 5th ed. Boston: Little Brown and Company; 1993: 283-334.
25. Shultz TD, Fox TD, Health H III, Kumar R. Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination. Proc Natl Acad Sci USA. 1983; 80: 1746-1750.
26. Ghazali A, Fardellone P, Pruna A, et al. Is low plasma 25-(OH) vitamin D a mayor risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int. 1999; 55: 2169-2177.
27. Dhesi JK, Bearne LM, Moniz C, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res. 2002; 17: 891-897.
28. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003; 88: 5766-5772.
29. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003; 78: 1463-1470.
30. Shah N, Bernardini J, Piraino B. Prevalence and correction of 25 (OH) D deficiency in peritoneal dialysis patients. Perit Dial Int. 2005; 25: 362-366.
31. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72: 690-693.
32. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels a population-based study in older men and women. J Clin Endocrinol Metab. 2005; 90: 4119-4123.
33. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003; 88: 157-161.
34. Fradinger EE, Zanchetta JRL. Vitamin D levels in women of the city of Buenos Aires. Medicina (Buenos Aires). 1999; 59: 449-452.